Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice
Patent
1998-04-07
1999-11-23
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Cosmetic, antiperspirant, dentifrice
424441, 424630, 424641, A61K 600, A61K 700, A61K 3334, A01N 5920
Patent
active
059895748
ABSTRACT:
A composition efficacious in aiding weight loss in humans includes a weight-reducing dosage of zinc acetate packaged together with a copper-depletion-preventing dosage of copper gluconate. The zinc acetate is present as essentially the sole active ingredient. The method of using the composition preferably includes administering the zinc acetate and copper gluconate three times per day. In an alternate embodiment, the composition may be administered twice per day. In addition, it has been found that the composition's efficacy is maximized by also imposing a low-fat dietary regime.
REFERENCES:
patent: 4144357 (1979-03-01), Mohammed
patent: 4393049 (1983-07-01), Horrobin
patent: 4784861 (1988-11-01), Gori
patent: 5215750 (1993-06-01), Keane, II
"Losing Weight Safely", Marilynn Larkin, FDA Consumer Magazine, Jan.-Feb. 1996, FDA Home Page excerpt, pp. 1-4.
"The Facts about Weight Loss Products and Programs", Presented as a Public Service by: Federal Trade Commission, Food and Drug Administration, National Association of Attorneys General, FDA/CFSAN Excerpt from U.S. Food and Drug Administration FDA/FTC/NAAG Brochure: 1992, pp. 1-4.
"Treatment of Wilson's Disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis", GJ Brewer, RD Dick, V Ysbasiayan-Gurkan, V Johnson, Y Wang, Dept. of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48103, Medline Record excerpt from Journal of Laboratory and Clinical Medicine, Jun. 1994, vol. 123 @ pp. 849-858, pp. 1-2.
"Wilson Disease", GJ Brewer, V Yusbasiyan-Gurkan, Dept. of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48103, Medicine, 1993, vol. 71, No. 3, pp. 139-164.
Interactions of zinc and molybdenum with copper in therapy of Wilson's Disease, GJ Brewer, Dept. of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48103, Medline Record excerpt from Nutrition, Jan.-Feb. 1995, vol. 11 @pp. 114-116, p. 1.
Howard Sharon
Page Thurman K.
LandOfFree
Weight loss compound and method of using does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Weight loss compound and method of using, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Weight loss compound and method of using will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1218404